16
virus 14 , we hypothesized that ZIKV infection manipulates the cellular NMD pathway. 48
To determine if ZIKV infection affects NMD, we infected human hepatic cells (the Huh7 49 cell line) and human induced pluripotent stem cell (iPSC)-derived NPCs, two relevant target cell 50 types, with ZIKV for 48 h. We isolated total RNA from infected cells and measured mRNA levels 51 of three canonical NMD substrates: asparagine synthetase (ASNS), cysteinyl-tRNA synthetase elevated in Huh7 cells and NPCs following infection with Asian lineage ZIKV strain P6-740 ( Fig.  54 1a). Levels of NMD substrates were also elevated in Huh7 cells infected with the contemporary 55 ZIKV clinical isolate PRVABC59 (Puerto Rico, 2015)( Fig. 1a ). We found that ZIKV-induced 56 increase in NMD transcripts did not reflect a global increase in transcription, as mRNA levels of 57 housekeeping genes, including glyceraldehyde 3-phosphate dehydrogenase (GAPDH), were 58 not altered in infected cells (Fig. 1a ). Together, these results indicate that ZIKV disrupts the 59 NMD pathway during infection. 60 NMD substrates are regulated through the activity of UPF1, an evolutionarily conserved 61 ATP-dependent RNA helicase. UPF1 plays a central role in the NMD pathway by linking the 62 translation termination event to the assembly of a surveillance complex, resulting in NMD 63 activation 15 . To determine if ZIKV infection more broadly affects NMD, we utilized two publicly 64 available RNA sequencing (RNA-Seq) datasets to compare genome-wide transcriptional 65 alterations found during ZIKV infection 16 to those found following UPF1 knockdown 17 . As shown 66 in Figure 1b , there is a significant overlap in upregulated genes between these two datasets. 67
Interestingly, several of the overlapping genes are involved in cell cycle arrest and induction of 68 apoptosis, two conditions linked to ZIKV-associated neuropathology 1 . These genes include DNA 69 damage-inducible transcript 3 (DDIT3) 18 and growth arrest and DNA damage-inducible protein 70 interactions between ZIKV and the NMD pathway, we separately analyzed data generated from 80 an affinity purification-mass spectrometry (AP-MS) screen to specifically query whether the 81 capsid protein of ZIKV interacts with NMD-associated host factors (Shah et al., submitted) . 82 ZIKV-host protein-protein interaction (PPI) maps were generated in HEK293T cells using ZIKV 83 proteins from the Ugandan 1947 strain MR 766 or the French Polynesian 2013 strain H/PF/2013 84 as bait proteins. From this analysis, we found that ZIKV capsid proteins interacted with several 85 factors of the NMD pathway, including multiple members of the EJC complex, as well as UPF1 86 and UPF3B (UPF3B is an NMD effector that stimulates the helicase activity of UPF1) ( Fig. 2a ). 87 Importantly, the NMD host factors that interact with each of the two different capsid proteins 88 greatly overlapped, revealing that the interaction between capsid and the NMD pathway is 89 conserved across the Asian and African lineages of ZIKV ( Fig. 2a ). 90
Next, we validated the binding of ZIKV capsid to UPF proteins by co-91 immunoprecipitating Flag-tagged capsid protein with endogenous UPF3B or UPF1 in HEK293T 92 cells. Both UPF3B and UPF1 proteins co-immunoprecipitated with ZIKV capsid, confirming the 93 AP-MS results (Fig. 2b ,c, respectively). In addition, ZIKV capsid colocalized with endogenous 94 UPF1 in transfected Huh7-Lunet cells, as visualized and quantified by confocal 95 immunofluorescent microscopy and three-dimensional (3D) reconstruction analysis (Mander's 96 colocalization coefficient of ~57%) ( Fig. 2d ). 97 Surprisingly, we consistently observed a decrease in UPF1, but not UPF3B, protein 98 levels in the input lysate of ZIKV capsid-transfected cells, pointing to a specific perturbation of 99 UPF1 expression by ZIKV capsid (Fig. 2c ). To confirm that UPF1 protein levels are 100 dysregulated during de novo ZIKV infection, we performed western blot analysis of infected 101
Huh7 cells and NPCs. Cellular UPF1 protein levels were consistently downregulated by ~50% in 102 ZIKV-infected Huh7 cells, whereas a ~25% reduction was observed in ZIKV-infected NPCs (Fig. efficiencies achieved in these two cell systems. UPF1 transcript levels were not decreased in transcriptionally downregulated during ZIKV infection ( Fig. 3c,d , respectively). 107
We hypothesized that UPF1 serves as a restriction factor of ZIKV and is inactivated in 108 infected cells to promote ZIKV propagation. To test this hypothesis, we decreased UPF1 109 expression prior to ZIKV infection by transfecting NPCs with either non-targeting siRNA or a 110 pool of UPF1-specific siRNAs. We then infected the transfected cells with ZIKV and measured 111 viral RNA levels, as well as infectious titers, 48 h post-infection (hpi). UPF1 knockdown was 112 successful in siRNA-treated cells, as confirmed by western blot analysis (Fig. 4a ). The depletion 113 of UPF1 in NPCs prior to infection resulted in a significant increase in both ZIKV RNA levels and 114 infectious virus production ( Fig. 4b ,c respectively), supporting the model that expression of 115 UPF1 restricts ZIKV infection at or before the RNA replication stage. During viral RNA 116 replication, double-stranded RNA (dsRNA) intermediates are generated, which can be 117 visualized with a specific antibody 20 . Using confocal microscopy and 3D reconstruction 118 analyses, we observed no significant difference in the number and size of dsRNA foci when we 119 compared ZIKV-infected, UPF1-depleted NPCs to ZIKV-infected cells expressing UPF1 120 (Supplemental Fig. 1 ). Instead, we found a significant increase in the number of infected cells in 121 NPC cultures when UPF1 was depleted, underscoring that UPF1 expression affects the 122 permissivity of NPCs to ZIKV infection ( Fig. 4d ), Interestingly, endogenous UPF1 colocalized 123 with viral dsRNA with ~54% of the 3D-reconstructed RNA replication loci also scoring positive 124 for UPF1 fluorescence, indicating that UPF1 targets ZIKV at the RNA replication stage ( Fig. 4e ).
protein complexes in these assays, especially when UPF1 was overexpressed, but further 131 studies are needed to conclusively show UPF1-dependent processing of ZIKV RNA. 132
In summary, we identified the NMD pathway as a restriction mechanism for ZIKV 133 infection in human NPCs. NMD was partially inactivated in ZIKV-infected NPCs through 134 expression of the viral capsid protein and the resulting downregulation of host UPF1 protein 135 levels. As further weakening NMD by depleting UPF1 results in a marked increase in the 136 number of infected cells, we propose a model in which an "arms race" between cellular NMD 137 and ZIKV determines whether a cell is successfully infected (Figure 4g 
